Enniatin A inhibits the chaperone Hsp90 and unleashes the immune system against triple-negative breast cancer.

iScience · 2023 · PMC10663837 · PMID 38025772

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Thus, the loss of PD-L1 in cancer cells upon EnnA treatment is highly significant in promoting antitumor immunity.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.